AzPA ANNUAL CONVENTION

JUNE 20-23, 2019 | TUCSON, AZ

This four-day annual conference provides continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings. Earn over 18 hours of CPE!

DUELING PIANO SHOW

JUNE 21st | 8:30-10:30PM

Your Voice-Your Profession-Your Opportunity to support Arizona Pharmacy! Join us for this fundraising event at the Westin La Paloma in Tucson, AZ (Grand Ballroom)

PharmPAC is a non-partisan voluntary committee that allows us to pool our financial resources to advance pharmacy by supporting pieces of legislation and state candidates who appreciate the value of our profession. With your support we can work effectively together for the good of our profession.

Immunization Certificate Program

JUNE 20TH | TUCSON, AZ

An innovative and interactive educational program that provides pharmacists and student pharmacists with the skills necessary to become primary sources for vaccine advocacy, education, and administration. The two-part program reviews the basics of immunology, identifies legal and regulatory issues pharmacists must consider before starting an immunization program.

Psychiatric Certificate Program

JUNE 20TH | TUCSON, AZ

Practice-based activity designed for pharmacists in all practice settings. The intent of this training program is to provide additional training in the area of psychiatric pharmacy to enhance pharmacists’ clinical knowledge that can be applied directly to the patients they serve.

Educate

Learn with us

Advocate

Discover your voice

Connect

Get involved! Serve on a team

RSS AzPA Pharmacy Flash

  • Where Teva failed, Eli Lilly gained — migraine drug Emgality wins US approval for episodic cluster headaches
    It may be trailing behind its rivals in migraine sales, but Lilly’s Emgality has secured the FDA nod for episodic cluster headaches. Emgality was the last injectable to win approval for migraine prevention last September, months after Aimovig from Amgen and Novartis, and Teva’s Ajovy. All three form part of a family of drugs developed […]
  • New breast cancer drug found to boost survival rates by 30%
    A new form of drug drastically improves survival rates of younger women with the most common type of breast cancer, researchers said recently, citing the results of an international clinical trial. The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of cell-cycle inhibitor ribociclib […]
  • FDA requests comments on blister packaging for certain opioids
    Specifically, FDA wants to know which opioid or opioid-containing products are appropriate candidates for such packaging. FDA is soliciting feedback through a public docket. The new requirement is part of the SUPPORT Act law, which allows FDA to require special packaging for opioids and other drugs that have the potential for abuse or come with […]

Upcoming Events

Upcoming Events

APhA Pharmacist & Patient- Centered Diabetes Care

06/20/2019

AzPA Immunization Training Certificate Program

06/20/2019

AzPA Psychiatric Certificate Program

06/20/2019

AzPA 2019 Annual Convention

06/21/2019

APhA Pharmacy Based Travel Health Services

06/21/2019

Pain Management Certificate Program

07/27/2019

FDA Immunization Certificate Program

07/29/2019

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA

ENDORSED PARTNER OF AzPA